Advertisement
Visit TheBody.com for Patient Education
You are not currently logged in.
Login
or
Register
Sign up for free e-mail/fax newsletters!
E-Mail
Share
Mitochondrial Toxicity
Overview
|
Research
Overview
Does Mitochondrial Toxicity Drive Lipoatrophy?
(July 2003)
[Archived Article]
Highlights from the IAPAC Sessions 2003.
In
IAPAC Monthly
, from
International Association of Physicians in AIDS Care
Mitochondrial Toxicity and Lactic Acidosis Fact Sheet
(April 2001)
[Archived Article]
To read PDF,
click here
.
From
Project Inform
Research
ddI + Ribavirin May Cause Mitochondrial Toxicity
(September 1, 2005)
In
Journal of Acquired Immune Deficiency Syndromes
Abstract 19: Uridine Prevents and Treats mtDNA Depletion by NRTI Pyrimidine Analogs and Fully Restores Mitochondrial Function
(October 1, 2003)
In
IAPAC Monthly
, from
International Association of Physicians in AIDS Care
Ask the Expert: Case Study -- 38-Year-Old Woman With Persistent Flu-Like Symptoms
(June 2003)
[Archived Article]
To read PDF,
click here
.
In
HEPP Report
, from
Brown Medical School
Study Finds Protease Inhibitors May Help Cause Lipodystrophy
(October 30, 2002)
[Archived Article]
In
CDC HIV/Hepatitis/STD/TB Prevention News Update
, from
U.S. Centers for Disease Control and Prevention
The Case Against Zerit
(October 2002)
[Archived Article]
Research increasingly points to NRTIs -- particularly d4T -- as a likely culprit in metabolic disorders.
In
GMHC Treatment Issues
, from
Gay Men's Health Crisis
Mitochondrial Toxicity in HAART
(September 2002)
[Archived Article]
A review of the latest research.
In
The PRN Notebook
Mitochondrial Damage
(Fall 2002)
[Archived Article]
To read PDF,
click here
.
In
STEP Perspective
, from
Seattle Treatment Education Project
E-Mail
Share
Aging With Complex Chronic Disease: The Wrinkled Face of AIDS
Showing Sero-Different Couples Some Respect
AIDS 2010 Roundup: Men Who Have Sex With Men (MSM)
HIV and Inflammation: A New Threat
Raltegravir Lovefest, Vienna Edition: AIDS 2010 Studies Explore Various Strategies for Use -- A Blog Entry by Myles Helfand
More >>
Advertisement